Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 138653, 5 pages
http://dx.doi.org/10.1155/2014/138653
Research Article

CHADS2 Scores in the Prediction of Major Adverse Cardiovascular Events in Patients with Cushing’s Syndrome

1Department of Nuclear Medicine, Dalin Tzu Chi General Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan
2School of Medicine, Tzu Chi University, Hualian, Taiwan
3Department of Pharmacy, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan
4Division of Rheumatology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan
5Department of Education, Dalin Tzu Chi General Hospital, No. 2 Ming-Sheng Road, Dalin Town, Chiayi 62247, Taiwan
6Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No. 2 Ming-Sheng Road, Dalin Town, Chiayi 62247, Taiwan
7Cancer Center, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan
8Department of Otolaryngology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan
9Center for Clinical Epidemiology and Biostatistics, Dalin Tzu Chi General Hospital, No. 2 Ming-Sheng Road, Dalin Town, Chiayi 62247, Taiwan

Received 2 April 2014; Revised 8 June 2014; Accepted 9 June 2014; Published 1 July 2014

Academic Editor: Gian Paolo Rossi

Copyright © 2014 Yuh-Feng Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Castinetti, I. Morange, B. Conte-Devolx, and T. Brue, “Cushings disease,” Orphanet Journal of Rare Diseases, vol. 7, no. 1, article 41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Obiols Alfonso, B. Biagetti Biagetti, A. Chacon Oreja, and J. Salvador Rodriguez, “Cushing's disease in 2012,” Endocrinología y Nutrición, vol. 61, no. 2, pp. 93–99, 2014. View at Google Scholar
  3. X. Bertagna, L. Guignat, L. Groussin, and J. Bertherat, “Cushing's disease,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 23, no. 5, pp. 607–623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. L. K. Nieman, B. M. Biller, J. W. Findling et al., “The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 5, pp. 1526–1540, 2008. View at Publisher · View at Google Scholar
  5. M. Minetto, G. Reimondo, G. Osella, M. Ventura, A. Angeli, and M. Terzolo, “Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome,” Osteoporosis International, vol. 15, no. 11, pp. 855–861, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Mancini, B. Kola, F. Mantero, M. Boscaro, and G. Arnaldi, “High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines,” Clinical Endocrinology, vol. 61, no. 6, pp. 768–777, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. G. di Dalmazi, V. Vicennati, S. Garelli et al., “Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study,” The Lancet Diabetes & Endocrinology, 2014. View at Google Scholar
  8. O. M. Dekkers, E. Horváth-Puhó, J. O. Jørgensen et al., “Multisystem morbidity and mortality in Cushing's syndrome: a cohort study,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 6, pp. 2277–2284, 2013. View at Publisher · View at Google Scholar
  9. C. Steffensen, A. M. Bak, K. Zøylner Rubeck, and J. O. L. Jørgensen, “Epidemiology of Cushing's syndrome,” Neuroendocrinology, vol. 92, no. 1, pp. 1–5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Baruch, B. F. Gage, J. Horrow et al., “Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?” Stroke, vol. 38, no. 9, pp. 2459–2463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. E. M. Hylek, C. Evans-Molina, C. Shea, L. E. Henault, and S. Regan, “Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation,” Circulation, vol. 115, no. 21, pp. 2689–2696, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Poli, E. Antonucci, R. Marcucci et al., “Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score,” Thrombosis Research, vol. 121, no. 3, pp. 347–352, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Fuster, L. E. Ryden, and D. S. Cannom, “ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation),” Journal of the American College of Cardiology, vol. 48, no. 4, pp. 854–906, 2006. View at Publisher · View at Google Scholar
  14. B. F. Gage, A. D. Waterman, W. Shannon, M. Boechler, M. W. Rich, and M. J. Radford, “Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation,” The Journal of the American Medical Association, vol. 285, no. 22, pp. 2864–2870, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Ruiz-Nodar, F. Marín, S. Manzano-Fernández et al., “An evaluation of the CHADS2 stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization,” Chest, vol. 139, no. 6, pp. 1402–1409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. H. Ruwald, A. Ruwald, C. Jons et al., “Evaluation of the chads2 risk score on short- and long-term all-cause and cardiovascular mortality after syncope,” Clinical Cardiology, vol. 36, no. 5, pp. 262–268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Hornero, E. Martin, F. Paredes et al., “Stroke after coronary artery bypass grafting: preoperative predictive accuracies of CHADS2 and CHA2DS2VASc stroke risk stratification schemes,” The Journal of Thoracic and Cardiovascular Surgery, vol. 144, no. 6, pp. 1428–1435, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Stöllberger, C. Wegner, and J. Finsterer, “CHADS2- and CHA2DS2VASc scores and embolic risk in left ventricular hypertrabeculation/noncompaction,” Journal of Stroke and Cerebrovascular Diseases, vol. 22, no. 6, pp. 709–712, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. T. L. Chiang, “Taiwan's 1995 health care reform,” Health Policy, vol. 39, no. 3, pp. 225–239, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. S.-C. Tung, P.-W. Wang, R.-T. Liu et al., “Clinical characteristics of endogenous cushings syndrome at a medical center in Southern Taiwan,” International Journal of Endocrinology, vol. 2013, Article ID 685375, 7 pages, 2013. View at Publisher · View at Google Scholar
  21. M. Yaneva, K. Kalinov, and S. Zacharieva, “Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center,” European Journal of Endocrinology, vol. 169, no. 5, pp. 621–627, 2013. View at Publisher · View at Google Scholar
  22. G. Ntali, A. Asimakopoulou, T. Siamatras et al., “Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up,” European Journal of Endocrinology, vol. 169, no. 5, pp. 715–723, 2013. View at Publisher · View at Google Scholar
  23. D. Graversen, P. Vestergaard, K. Stochholm, C. H. Gravholt, and J. O. L. Jørgensen, “Mortality in Cushing's syndrome: a systematic review and meta-analysis,” European Journal of Internal Medicine, vol. 23, no. 3, pp. 278–282, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Bolland, I. M. Holdaway, J. E. Berkeley et al., “Mortality and morbidity in Cushing's syndrome in New Zealand,” Clinical Endocrinology, vol. 75, no. 4, pp. 436–442, 2011. View at Publisher · View at Google Scholar · View at Scopus